Quest Diagnostics Incorporated (DGX) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States.

Total Assets Chart for Quest Diagnostics Incorporated

Quest Diagnostics Incorporated (DGX) total assets for FY2025 were USD 16.2B, a 0.4% change from FY2024. Quest Diagnostics Incorporated's total assets grew from USD 1.4B in 1996 to USD 16.2B in 2025 (1063.0% over 29 years). Total assets compound annual growth rate: 5-year CAGR of 3.0%, 10-year CAGR of 5.0%, 20-year CAGR of 5.7%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$26.32B
Implied Share Price
$238.50
Enterprise Value
$31.55B
Revenue (TTM)
$11.56B
EBITDA
$2.27B
Profit Margin
9.19%
Trailing P/E
25.35
Forward P/E
20.96
Price/Book (MRQ)
3.43
Price/Sales (TTM)
2.28
EV/EBITDA
14.01
EV/Revenue
2.73
Dividend Yield
1.41%
Book Value
$68.33
Free Cash Flow (FY2025)
$1.36B
Free Cash Flow Yield
5.16%

Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.